Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Salestools Logo

Salestools

Der #1 KI-Agent für Vertriebsteams und Go-to-Market-Teams. Verkaufen Sie mehr, schneller, mit weniger Aufwand.

Produkt

  • KI-Vertriebsagenten
  • Intent-Daten
  • Technologiedaten
  • Besucher-Tracking
  • Co-Pilot
  • Social Selling

Lösungen

  • Kundenservice
  • E-Commerce
  • SaaS
  • Enterprise
  • Kleinunternehmen

Ressourcen

  • Der Report
  • Dokumentation
  • API-Referenz
  • Hilfecenter
  • Blog
  • Fallstudien
  • Webinare

Unternehmen

  • Über uns
  • Karriere
  • Presse
  • Kontakt
  • Partner

Unsere Standorte

  • New York, HQ
  • Bukarest, KI-Forschungslabor
  • Zug, Schweiz

© 2025 Salestools. Alle Rechte vorbehalten.

Datenbedingungen & SicherheitDatenschutzerklärungNutzungsbedingungen
Alle Systeme betriebsbereit
Salestools LogoSalestools
Salestools KI-Agenten
Lösungen
Ressourcen
Unternehmen
Preise
Back to The Report
Fundraising

Danaher

Danaher Raises $180B in Public

1969
Founded
80000+
Employees
2200 Pennsylvania Avenue NW, Washington, DC 20037
Updated January 1, 2024
2 min read

Quick Facts

Danaher Raises $180B in Public


Danaher has successfully raised $180B in a Public at a $190B valuation led by Public.


Company Overview


Danaher is a Life Sciences company headquartered in 2200 Pennsylvania Avenue NW, Washington, DC 20037, founded in 1969 with 80000+ employees.


Science and technology conglomerate


Fundraising Details


  • Amount Raised: $180B
  • Round Type: Public
  • Valuation: $190B
  • Date: 2024-01-01
  • Investors: Public

About Danaher


Science and technology conglomerate The company is positioned in the Life Sciences sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: 2200 Pennsylvania Avenue NW, Washington, DC 20037
  • Founded: 1969
  • Team Size: 80000+
  • Industry: Life Sciences

What This Means


This funding round demonstrates strong investor confidence in Danaher's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The Life Sciences sector continues to attract significant investment as companies innovate to meet evolving market demands. Danaher's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $190B valuation marks an important milestone for Danaher, positioning the company among notable players in the Life Sciences industry.


Looking Ahead


With this new capital, Danaher is well-positioned to execute on its growth strategy and continue building innovative solutions in the Life Sciences space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2024-01-01. For more information about Danaher, visit their headquarters at 2200 Pennsylvania Avenue NW, Washington, DC 20037.

Topics

Fundraising(2912)Public(771)Life SciencesDanaher

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million